Wahiduzzaman, M., Yasmin, A., Shahriar Hossain, M., Dhar, R., & Haider, M. M. (2025). Efficacy and safety of empagliflozin (SGLT2 inhibitor) in Bangladeshi patients with type 2 diabetes mellitus. International Journal of Research in Medical Sciences, 13(12), 5150–5154. https://doi.org/10.18203/2320-6012.ijrms20253934